The U.S. government is seeking damages against Gilead Sciences Inc. for allegedly infringing on government-owner patents for the HIV-prevention drug PrEP. The Department of Health and Human Services is alleging that Gilead has refused to license its ...
from Google Alert - health https://ift.tt/2CjCHuz
via IFTTT
0 comments:
Post a Comment